US20120114718A1 - Solid-state method for producing functionalized calcium phosphate hybrid organic/inorganic chemical systems for dental remineralization applications - Google Patents
Solid-state method for producing functionalized calcium phosphate hybrid organic/inorganic chemical systems for dental remineralization applications Download PDFInfo
- Publication number
- US20120114718A1 US20120114718A1 US13/105,268 US201113105268A US2012114718A1 US 20120114718 A1 US20120114718 A1 US 20120114718A1 US 201113105268 A US201113105268 A US 201113105268A US 2012114718 A1 US2012114718 A1 US 2012114718A1
- Authority
- US
- United States
- Prior art keywords
- organic
- inorganic
- dental
- precursor
- functionalized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 title claims abstract description 67
- 239000001506 calcium phosphate Substances 0.000 title claims abstract description 66
- 235000011010 calcium phosphates Nutrition 0.000 title claims abstract description 27
- 229910000389 calcium phosphate Inorganic materials 0.000 title claims abstract description 26
- 239000000126 substance Substances 0.000 title claims abstract description 11
- 238000003836 solid-state method Methods 0.000 title description 2
- 238000000034 method Methods 0.000 claims abstract description 43
- 239000000203 mixture Substances 0.000 claims abstract description 42
- 238000003801 milling Methods 0.000 claims abstract description 30
- 238000009472 formulation Methods 0.000 claims abstract description 19
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000011575 calcium Substances 0.000 claims abstract description 12
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 12
- 239000002245 particle Substances 0.000 claims abstract description 11
- 239000011368 organic material Substances 0.000 claims abstract description 8
- 229910010272 inorganic material Inorganic materials 0.000 claims abstract description 6
- 239000011147 inorganic material Substances 0.000 claims abstract description 6
- 150000002894 organic compounds Chemical class 0.000 claims abstract 3
- 239000000463 material Substances 0.000 claims description 54
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 38
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 37
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 36
- 229940078499 tricalcium phosphate Drugs 0.000 claims description 36
- 238000011282 treatment Methods 0.000 claims description 33
- 239000002243 precursor Substances 0.000 claims description 32
- 229920001223 polyethylene glycol Polymers 0.000 claims description 24
- 239000002202 Polyethylene glycol Substances 0.000 claims description 22
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 18
- 239000011707 mineral Substances 0.000 claims description 18
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 14
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 14
- 239000004094 surface-active agent Substances 0.000 claims description 13
- 230000015572 biosynthetic process Effects 0.000 claims description 12
- 229920001610 polycaprolactone Polymers 0.000 claims description 12
- 230000007935 neutral effect Effects 0.000 claims description 10
- 239000002966 varnish Substances 0.000 claims description 10
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 9
- 239000006072 paste Substances 0.000 claims description 9
- -1 poly(ethylene glycol) Polymers 0.000 claims description 9
- 239000004632 polycaprolactone Substances 0.000 claims description 9
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 8
- 229920000642 polymer Polymers 0.000 claims description 8
- 239000001530 fumaric acid Substances 0.000 claims description 7
- 239000003945 anionic surfactant Substances 0.000 claims description 6
- 239000003093 cationic surfactant Substances 0.000 claims description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 claims description 5
- 208000002925 dental caries Diseases 0.000 claims description 5
- 229940023487 dental product Drugs 0.000 claims description 5
- 230000001965 increasing effect Effects 0.000 claims description 5
- 210000005239 tubule Anatomy 0.000 claims description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- 125000001931 aliphatic group Chemical group 0.000 claims description 4
- 125000000129 anionic group Chemical group 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 150000001732 carboxylic acid derivatives Chemical group 0.000 claims description 4
- 150000001735 carboxylic acids Chemical class 0.000 claims description 4
- 229960001927 cetylpyridinium chloride Drugs 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 239000000499 gel Substances 0.000 claims description 4
- 239000000178 monomer Substances 0.000 claims description 4
- 229920001451 polypropylene glycol Polymers 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 229920000728 polyester Polymers 0.000 claims description 3
- 229920000570 polyether Polymers 0.000 claims description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 2
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 claims description 2
- 229920000463 Poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol) Polymers 0.000 claims description 2
- 229920000475 Poly(ethylene oxide)-block-polycaprolactone Polymers 0.000 claims description 2
- 239000004721 Polyphenylene oxide Substances 0.000 claims description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 2
- 235000021355 Stearic acid Nutrition 0.000 claims description 2
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 claims description 2
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 2
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 claims description 2
- 229940063953 ammonium lauryl sulfate Drugs 0.000 claims description 2
- 125000002091 cationic group Chemical group 0.000 claims description 2
- PXNMCSRWKJGCKH-UHFFFAOYSA-N decyl-dimethyl-(3-sulfooxypropyl)azanium;hydroxide Chemical compound [OH-].CCCCCCCCCC[N+](C)(C)CCCOS(O)(=O)=O PXNMCSRWKJGCKH-UHFFFAOYSA-N 0.000 claims description 2
- 201000002170 dentin sensitivity Diseases 0.000 claims description 2
- TYLSDUAZMMTWDM-UHFFFAOYSA-N dimethyl-nonyl-(3-sulfooxypropyl)azanium;hydroxide Chemical compound [OH-].CCCCCCCCC[N+](C)(C)CCCOS(O)(=O)=O TYLSDUAZMMTWDM-UHFFFAOYSA-N 0.000 claims description 2
- 150000002009 diols Chemical class 0.000 claims description 2
- SMVRDGHCVNAOIN-UHFFFAOYSA-L disodium;1-dodecoxydodecane;sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC SMVRDGHCVNAOIN-UHFFFAOYSA-L 0.000 claims description 2
- JMGZBMRVDHKMKB-UHFFFAOYSA-L disodium;2-sulfobutanedioate Chemical compound [Na+].[Na+].OS(=O)(=O)C(C([O-])=O)CC([O-])=O JMGZBMRVDHKMKB-UHFFFAOYSA-L 0.000 claims description 2
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 claims description 2
- 230000002708 enhancing effect Effects 0.000 claims description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 2
- 238000011049 filling Methods 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 claims description 2
- 239000011976 maleic acid Substances 0.000 claims description 2
- 239000001630 malic acid Substances 0.000 claims description 2
- 235000011090 malic acid Nutrition 0.000 claims description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 2
- FOUMXCVSWGOIHX-UHFFFAOYSA-M potassium;3-(4-nonylphenoxy)propane-1-sulfonate Chemical compound [K+].CCCCCCCCCC1=CC=C(OCCCS([O-])(=O)=O)C=C1 FOUMXCVSWGOIHX-UHFFFAOYSA-M 0.000 claims description 2
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 claims description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 239000008117 stearic acid Substances 0.000 claims description 2
- 230000036347 tooth sensitivity Effects 0.000 claims description 2
- 239000000606 toothpaste Substances 0.000 claims description 2
- 229940034610 toothpaste Drugs 0.000 claims description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 claims 6
- 235000010755 mineral Nutrition 0.000 claims 4
- 208000018035 Dental disease Diseases 0.000 claims 3
- 229920001400 block copolymer Polymers 0.000 claims 3
- 229920001577 copolymer Polymers 0.000 claims 3
- 239000011775 sodium fluoride Substances 0.000 claims 3
- 235000013024 sodium fluoride Nutrition 0.000 claims 3
- 230000008878 coupling Effects 0.000 claims 1
- 238000010168 coupling process Methods 0.000 claims 1
- 238000005859 coupling reaction Methods 0.000 claims 1
- 230000003292 diminished effect Effects 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- 229940051866 mouthwash Drugs 0.000 claims 1
- 230000003014 reinforcing effect Effects 0.000 claims 1
- 230000002194 synthesizing effect Effects 0.000 claims 1
- 210000003298 dental enamel Anatomy 0.000 description 23
- 239000000047 product Substances 0.000 description 19
- 238000005516 engineering process Methods 0.000 description 17
- 239000000654 additive Substances 0.000 description 14
- 239000000843 powder Substances 0.000 description 14
- 230000001351 cycling effect Effects 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 238000012360 testing method Methods 0.000 description 12
- 230000003902 lesion Effects 0.000 description 11
- 239000000120 Artificial Saliva Substances 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 8
- 238000000498 ball milling Methods 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 210000004268 dentin Anatomy 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- YUJLIIRMIAGMCQ-CIUDSAMLSA-N Ser-Leu-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YUJLIIRMIAGMCQ-CIUDSAMLSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000013642 negative control Substances 0.000 description 5
- 241000283690 Bos taurus Species 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 235000021443 coca cola Nutrition 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 241000519995 Stachys sylvatica Species 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 238000005115 demineralization Methods 0.000 description 3
- 230000002328 demineralizing effect Effects 0.000 description 3
- 210000004513 dentition Anatomy 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 230000036346 tooth eruption Effects 0.000 description 3
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 238000005275 alloying Methods 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
- 238000001311 chemical methods and process Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000013065 commercial product Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000551 dentifrice Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000009610 hypersensitivity Effects 0.000 description 2
- 238000007373 indentation Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000002086 nanomaterial Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000011269 treatment regimen Methods 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 238000001282 Kruskal–Wallis one-way analysis of variance Methods 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 1
- 229940078495 calcium phosphate dibasic Drugs 0.000 description 1
- 239000002041 carbon nanotube Substances 0.000 description 1
- 229910021393 carbon nanotube Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000012707 chemical precursor Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 210000001315 dental pellicle Anatomy 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000005553 drilling Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000004134 energy conservation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000010316 high energy milling Methods 0.000 description 1
- 238000001027 hydrothermal synthesis Methods 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000007040 multi-step synthesis reaction Methods 0.000 description 1
- 150000004767 nitrides Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000010397 one-hybrid screening Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000006259 organic additive Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 238000010951 particle size reduction Methods 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- HTYIXCKSEQQCJO-UHFFFAOYSA-N phenaglycodol Chemical compound CC(C)(O)C(C)(O)C1=CC=C(Cl)C=C1 HTYIXCKSEQQCJO-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 229940057950 sodium laureth sulfate Drugs 0.000 description 1
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 1
- 238000004729 solvothermal method Methods 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 239000013077 target material Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 238000007704 wet chemistry method Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
- A61K8/21—Fluorides; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B25/00—Phosphorus; Compounds thereof
- C01B25/16—Oxyacids of phosphorus; Salts thereof
- C01B25/26—Phosphates
- C01B25/32—Phosphates of magnesium, calcium, strontium, or barium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/70—Preparations for dentistry comprising inorganic additives
- A61K6/71—Fillers
- A61K6/74—Fillers comprising phosphorus-containing compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
- B23C—MILLING
- B23C2220/00—Details of milling processes
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
- C01F11/00—Compounds of calcium, strontium, or barium
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/32—Phosphorus-containing compounds
- C08K2003/321—Phosphates
- C08K2003/325—Calcium, strontium or barium phosphate
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T409/00—Gear cutting, milling, or planing
- Y10T409/30—Milling
Definitions
- the present novel technology relates generally to the field of chemical synthesis, and more particularly, to a method and system for producing functionalized hybrid moieties without the need for sophisticated chemistries.
- the present novel technology relates generally to the production of functionalized hybrid moieties without the need for sophisticated chemistries, and, more particularly to a solid-state method for producing the same.
- One object of the present novel technology is to provide an improved method for producing functionalized hybrid moieties for the purposes of delivering superior performance in oral care product formulations in the absence or presence of fluoride. Further objects, features, and advantages will become apparent from a consideration of the following description and accompanying drawings.
- FIG. 1 is a graph showing the change in Vickers microhardness results from remin/demin cycling study including a negative control group (water) and positive control ACP and test group ACP95PEG15, comprised of 95 and 5 weight percent of TCP and 1500 Da PEG.
- FIG. 2 is a graph showing the change in Vickers microhardness of human enamel after application of a 5% NaF commercially available varnish with and without the additive TCP 90 FA 10 , a construct of 90 wt. % TCP and 10 wt. % fumaric acid.
- FIG. 3 is a graph showing the change in Vickers microhardness results after 7 days of a pH cycling lesion reversal dental model in experimental groups including commercially available 5000 ppm fluoride products A and B (positive controls) and Product A combined with different functionalized calcium phosphates: TCP98SLS2 [construct of 98% TCP plus 2% sodium lauryl sulfate, SLS], TCP98PCL2 [construct of 98% TCP plus 2% 2000 Da polycaprolactone, PCL], or TCP95CPC5 [construct of 95% TCP plus 5% cetylpyridinium chloride, CPC].
- FIG. 4 is a graph showing enamel fluoride uptake results after 7 days of a pH cycling lesion reversal dental model in test groups including commercially available 5000 ppm fluoride products A and B, as well as Product A combined with different functionalized calcium phosphates: TCP98SLS2 [construct of 98% TCP plus 2% sodium lauryl sulfate, SLS], TCP98PCL2 [construct of 98% TCP plus 2% 2000 Da polycaprolactone, PCL], or TCP95CPC5 [construct of 95% TCP plus 5% cetylpyridinium chloride, CPC].
- the present novel technology relates to a method of combination of organic and inorganic chemical systems in such a way as to eliminate the usual synthetic procedures requiring 1) temperature variations (both hot and cold), 2) the need for volatile solvents to effectuate dissolution of one or more phases to be blended, 3) vacuum or inert environment conditions to reduce oxygen or water vapor interaction, 4) templating molecules, 5) the usual overhead in terms of laboratory space, equipment, professional expertise in terms of synthesis. Additionally, the method may be easily scaled from the synthesis of gram amounts to the synthesis of tons, overcoming a production limitation that economically and operationally impedes the use of known functionalizing chemistries for large scale production of functionalized materials.
- the present novel technology includes a method for producing a thermodynamically and kinetically stable material that slowly releases ions and moieties due to the complex chemistry created during the alloying process.
- the technique was developed to address a need for improved dental applications, and, accordingly, the following examples and embodiments tend to reflect chemistries having dental applications.
- the present novel method for producing functionalized chemistries is broadly applicable beyond the dental applications discussed herein.
- the hybrid materials may coexist with fluoride and do not compromise fluoride bioavailability.
- the formation and/or retention of chemical structures facilitate and modulate interactions among the hybrid materials and other components when added to condensed phases.
- the functionalized surface aids in promoting direct contact between a target material (such as a pellicle, enamel, intestinal walls or the like), and therefore allows for more efficient delivery of a desired active component.
- the present novel technology may be used to generate functionalized hybrid materials on a nano-, meso-, and/or macroscale.
- the characteristics and properties of these materials typically include one or more of the following:
- Mechanochemical (MC) ball milling not only reduces particle size but also impacts particles with sufficient force that such disparate materials as oxides, ceramics, organic powders and the like maybe chemically combined together to form new alloys or composites.
- This mechanochemical synthesis process occurs entirely in the solid state. This capability separates MC ball mills from traditional mills. This destructive process deforms components through powerful collisions between ball-particle, particle-wall, and particle-particle. These collisions are sufficiently energetic to give rise to the formation of significant grain boundaries at the nanoscale where components have fractured and fused.
- the vessel containing the balls and material is typically rotated at high speed opposite to the direction of rotation of the platform on which the vessel is placed (i.e., mimicking ‘tilt-a-whirl’ motions).
- the vessel is rotated in a first direction about an axis of rotation not passing through the vessel (i.e., the axis of rotation of the platform) while simultaneously rotated or spun in a second direction (i.e., about a second axis of rotation that is nonparallel to the first axis of rotation and typically, though not necessarily, passes through the vessel) to impart sufficient kinetic energy to the admixture within the vessel to both break down the precursor component parts of the admixture and fuse them together to generate a new hybrid compound.
- the resultant hybrid nanomaterials formed from these concurrent physical and chemical processes enable material synthesis to extend beyond both what is typical of usual wet laboratory synthetic procedures and of ball milling in a wet medium.
- one such opportunity relates to the extraction of elements from fluorescent powder for energy conservation.
- MC ball milling has been employed to improve nitrogen absorption characteristics of better materials as well as to synthesize nanoscale graphite platelets as an alternative to carbon nanotubes.
- Milling additives have been used in MC ball milling to improve properties of the milled material, but these additions have been primarily directed at expediting particle size reduction.
- the present novel technology uses MC ball milling for more than the simple reduction of the physical dimensions of the particles, but instead as a starting point for specific chemical modification to generate novel materials with improved properties and characteristics, such as when added to various formulations.
- MC milling is readily scaleable to met industrial demands.
- one robust industry-scale planetary ball mill has a commercial capacity ranging between 100 and 900 liters, and MC milling technology is currently used in developing improved nanosized pigments for coatings, lotions, and paints.
- the current novel technology introduces efficiencies of cost, time, and scale of producing functionalized hybrid moieties without the need for complex and sophisticated wet chemistries.
- the resulting scalability may then be realized for various applications, for example where localized, slow-releasing chemical, mineral or drug delivery is desired.
- Functionalizing systems to specifically adsorb to target areas offers alternatives for more effective therapeutic or chemical treatments.
- the novel chemical synthesis method exploits the mechanochemical ball milling process to produce a relatively great amount of relatively inexpensive functionalized complexes.
- the functionalized complexes are blends of independent organic and inorganic reagents coupled together to yield a hybrid material with enhanced properties.
- a typical inorganic material includes a calcium phosphate mineral such as calcium phosphate tribasic, calcium phosphate dibasic, dicalcium phosphate, and the like.
- other inorganic materials may include sodium, magnesium, iron, silicon, aluminum, manganese, titanium and the like in various mineralogical forms (carbonates, nitrides and the like).
- Typical organic materials include anionic surfactants (such as sodium lauryl sulfate, sodium lauryl ether sulfate, ammonium lauryl sulfate, N,N-Dimethyl-N-[3-(sulfoxy)propyl]-1-nonanaminium hydroxide inner salt, sodium dodecylbenzenesulfonate, poly(ethylene glycol) 4-nonylphenyl 3-sulfopropyl ether potassium salt, doctyl sulfosuccinate sodium salt, and the like), cationic surfactants (such as pyridinium chloride, hexadecyltrimethylammonium bromide, N,N-dimethyl-N-[3-(sulfoxy)propyl]-1-decanaminium hydroxide inner salt, and the like), neutral surfactants—polyethers or polyesters (such as polyethylene glycol, polypropylene glycol (PPG), poly(ethylene glyco
- the organic materials may include those with properties akin to the anionic surfactants listed above (i.e., materials having anionic terminal groups (such as sulfates, sulfonates, or carboxylates), having cationic species ionically bound (such as sodium or potassium ions), having aliphatic chain lengths up to 12 carbon atoms or even more, and/or having the character of sodium lauryl sulfate in its structures (such as sodium laureth sulfate, which manifests n-number of ethoxy groups (OCH 2 CH 2 ) n )), having properties akin to the cationic surfactants listed above (i.e., having quaternary ammonium cation character manifested in a conjugated carbon ring, having anionic species ionically bound (such as chlorine and bromide ions), and/or having aliphatic chain lengths up to 17 carbon atoms or more), having properties akin to the polyether surfactants listed above
- hybrid polymer-calcium phosphate systems may be produced in various formulations for improving remineralization efficacy of a fluoride rinse or paste or reducing tooth sensitivity in a paste or varnish.
- the preparation of organic-inorganic materials via a mechanochemical process is described as follows.
- the mixture may range from between about 0.5 and 99.5 weight percent inorganic precursor material, with the balance being organic precursor material.
- the inorganic starting material is tricalcium phosphate, while the organic starting material is polyethylene glycol; however, any convenient inorganic and organic precursors may be selected.
- Tricalcium phosphate (TCP, Ca 3 (PO 4 ) 2 ) may be purchased from a chemical vendor directly or may be formed by adding equal masses of calcium carbonate (CaCO 3 ) and dibasic calcium phosphate (CaHPO 4 .2H 2 O) to a refractory crucible and heating the mixture in an oven at about 1050° C. for about 24 hours to produce a resultant flaky, stiff powder crystalline TCP.
- TCP plus polyethylene glycol (PEG) having any one of various molecular weights (such as 600, 1500, and 6000 Da) may be added to a stainless steel vessel containing a plurality of milling media balls, such as about twenty-five 10 millimeter diameter stainless steel balls.
- PEG is typically substituted for TCP between 0 and 20 weight percent (wt. %). Additionally, a small amount of organic solvent, such as pentane, may be added to not only swell the PEG to encourage more uniform blending, but also to help prevent powder from caking onto the balls and walls of the vessel.
- organic solvent such as pentane
- the vessel is typically locked onto the sun wheel of a planetary ball mill. The vessel is then rotated unidirectionally and opposite the rotational direction of the sun wheel at a sufficiently high speed for a duration of time sufficient to yield functionalized chemical moieties, such as, for example, at about 550 rpm or more for about two hours. At the end of the milling process the resulting powders are then filtered from the balls and stored, such as in plastic containers.
- particle-size measurements of so-produced powders typically revealed particle size distributions between 100 and 1000 nm, depending on the powder formulation. Even smaller sizes along grain boundaries may exist due to extensive breakdown and recombination or ‘welding’ of the particulates during the MC milling process. Also, the texture and appearance of the powders may vary considerably with the composition of the selected organic and inorganic precursors, the milling media composition, size and number, the milling energy, the milling time, and like factors. For instance, milling the TCP powder in the absence of PEG typically produces fine, hard particles, while milling in the presence of PEG, however, powders that vary from fluffy and soft to inflexible and coarse with increasing PEG molecular weight and content. These rudimentary powder observations suggest a composite-like material might have been formed, as neither the singular forms of TCP nor the PEG exhibit such characteristics.
- the integrity of the P 2 O 5 network and calcium environments inherent to a calcium phosphate mineral can be modified with the addition of an organic additive (e.g., a polymer having varied molecular weight and chemical character, a surfactant such as SLS, and a carboxylic acid such as fumaric acid) and prepared under a variety of milling conditions.
- an organic additive e.g., a polymer having varied molecular weight and chemical character, a surfactant such as SLS, and a carboxylic acid such as fumaric acid
- solid-state interactions between the calcium phosphate material and the organic component create functionalized calcium phosphate hybrid materials with widely varying chemical and physical properties depending on material components and milling conditions.
- any added materials to the formulation do not inhibit the bioavailability (typically greater than ⁇ 50% of the theoretical ppm level, more typically greater than ⁇ 10% of the theoretical ppm level) or action of fluoride.
- a pilot study assessing the compatibility potential of a TCP (tricalcium phosphate)—PEG (polyethylene glycol) nanocomplex material prepared according to the novel methodology herein when added to NaF(aq) over a period of 26 days did not reduce fluoride bioavailability greater than 10%, while a soluble form of calcium acting as a control reduced bioavailable fluoride nearly 60%.
- TCP and PEG precursors were introduced into a MC mill and were milled with sufficient energies to break down the organic and inorganic precursors into organic and inorganic components and fuse or couple the components to form functionalized complexes or moieties.
- Other compatibility studies with different functionalized calcium phosphates for example, TCP 98 SLS 2 , which is a construct of 98% TCP plus 2% sodium lauryl sulfate, SLS
- 500, 1100, and 5000 ppm fluoride (from NaF) have shown less than 10% bioavailable fluoride reduction over an accelerated aging period (temperature set to 40° C.) of at least 30 days (which is the equivalent to approximately 6 months at 20° C.).
- TCP is tricalcium phosphate and TCP X PEG y represents an alloyed material comprised of 1500 Da PEG, where x represents the weight percent of TCP in the composite (i.e. 95%) and y represents the fraction of PEG (i.e. 5%).
- test materials (groups 2 and 3) were prepared using a solid-state mechanochemical milling procedure that pulverized 20 grams of thermally prepared TCP for 2 hours at 550 rpms, unidirectionally, using twenty-four 10 mm diameter stainless steel balls and 20 ml of pentane. After milling, the powder was extracted from the mill jar and placed in 120 ml plastic containers. Groups 2 and 3 had 0 and 5 wt. % of PEG added, respectively, to the TCP prior to the two hours of milling/alloying.
- Enamel specimens (5 mm ⁇ 5 mm) were removed from extracted bovine teeth and mounted in rods. The specimens were ground and polished to a high luster with Gamma Alumina using standard methods. Ten specimens per group were prepared for this study.
- the mass of the treatment powders was 30 mg (for a weight fraction of 6% with respect to the 5 g of water). There were a total of 20 treatments per group. There were a total of 3 groups in this study and they are identified as follows:
- the cyclic treatment regimen consisted of a 4.0 hour/day acid challenge in the lesion forming solution and four, one-minute dentifrice treatment periods. After the treatments, the specimens were rinsed with running distilled water and then placed back into the artificial saliva. The remaining time ( ⁇ 21 hours) the specimens were in an artificial saliva/remineralization system. The regimen was repeated for 5 days.
- Remineralization was determined by comparing the Vickers surface microhardness after treatment (post) to that before treatment (baseline).
- novel technology hybrid material prepared according to the novel methods disclosed herein may produce increased levels of remineralization relative to an unfunctionalized calcium phosphate when used in a standard pH cycling lesion reversal model.
- Calcium phosphate additives were prepared by blending fumaric acid with tricalcium phosphate.
- the fumaric acid has a high melting point ( ⁇ 300 degrees Celsius) and manifests an unsaturated environment that can be activated to react with, for example, the tricalcium phosphate when subjected to high impact forces and energies inherent in the novel mechanochemical process discussed herein.
- the following data report the application findings when this high temperature, unsaturated organic molecule is blended forcibly with an inorganic salt (tricalcium phosphate) to yield a dental treatment complex and implemented into a tooth surface introduction medium, such as a fluoride-containing commercial varnish having 5% NaF.
- the SNK method was used determine where the differences occurred (p ⁇ 0.05). Only the 5% NaF Varnish+1 wt. % TCP 90 FA 10 system was statistically different from the Placebo group; the other two groups were statistically equivalent (see FIG. 2 ).
- Additives comprised of sodium lauryl sulfate, cetylpyridinium chloride, polycaprolactone and tricalcium phosphate and validated in a pH cycling lesion reversal remineralization model
- prescription-based NaF toothpaste is suggested for certain population groups most at risk for developing caries. These pastes typically have 5000 ppm F and are used at least once daily as a replacement for the conventional 1100 ppm F paste in order to provide increased protection. To further increase protection, improved performance can be achieved with custom-made calcium phosphate additives that have been added to existing tooth care formulations, such as commercially available 5000 ppm F dentifrice formulations. In one screening study, the extent of remineralization and fluoride uptake into white-spot enamel lesions when treated with modified tooth care formulations was investigated.
- the protocol for this screening study was performed as follows. Bovine enamel specimens were demineralized for 40 hours in a Carbopol-lactic acid ‘white-spot’ solution. White-spot lesions of approximately 70 microns were formed. The specimen microhardness ranged between 25 and 45 Vickers hardness numbers. Three enamel specimens were used for each of the treatment groups.
- the treatment groups consisted of a negative control (DI water), positive commercially available 5000 ppm F controls (product A and B), and experimental test groups comprised of commercially available product A combined with various additives.
- artificial saliva was added to the test formulation in a 1:2 ratio (e.g. 5 g paste, 10 g artificial saliva).
- the remineralization/demineralization pH cycling model used to evaluate the efficacy of the test groups is described as follows. Each 24-hour period consisted of four, two minute treatments from the groups described above, one, four-hour acid challenge emulating caries formation, and the remaining time the specimens were immersed in artificial saliva. The cycle was repeated for seven days, after which post microhardness and fluoride uptake measurements were performed on all enamel specimens.
- Group 1 Water (negative control)
- That fluoride-stable additives can improve fluoride uptake and remineralization and indicate that these agents function synergistically with the 5000 ppm F Product A formulation when examined in a seven day pH cycling model. The overall effect is a net remineralization of enamel. The additives do not appear to compromise and can improve the performance of Product A.
- the specimens were immersed in artificial saliva.
- the treatment pastes were diluted with DI water in a ratio of 1:3 (i.e. 5 ml of test solution: 15 ml DI water).
- the treatments consisted of: (a) a commercially available product for reducing dentinal hypersensitivity by occluding exposed dentinal tubules; (b) a similar product containing 1100 ppm fluoride to which 0.05% TCP98SLS had been added; (c) a similar product containing 5000 ppm fluoride; and (d) the latter product to which 0.1% TP98SLS2 had been added.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Birds (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cosmetics (AREA)
- Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
- Materials For Medical Uses (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
Abstract
A method of repairing weakened teeth, including combining a first predetermined amount of an inorganic calcium source with a second predetermined amount of an organic material to define a mixture, placing the mixture in a milling vessel operationally connected to a planetary mill, introducing milling media into the milling vessel, milling the mixture to impart sufficient kinetic energy to break down the organic and inorganic materials into substantially smaller intermediate particles and fuse the intermediate particles together to yield functionalized molecules having both organic and inorganic chemical characteristics, combining a functionalized calcium phosphate/organic compound with a fluoridated formulation to define a hybrid system, and applying the hybrid system to the weakened teeth.
Description
- This application claims priority to co-pending U.S. patent application Ser. No. 12/018,627, filed Jan. 23, 2008, which claimed priority to then co-pending U.S. provisional patent application Ser. No. 60/888,354, filed Feb. 6, 2007, then co-pending U.S. provisional patent application Ser. No. 60/891,849, filed Feb. 27, 2007, and then co-pending U.S. provisional patent application Ser. No. 60/941,095, filed May 31, 2007.
- The present novel technology relates generally to the field of chemical synthesis, and more particularly, to a method and system for producing functionalized hybrid moieties without the need for sophisticated chemistries.
- Preventing caries and cavities and improving the delivery of minerals necessary to healthy teeth and bone, while preserving and/or enhancing cosmetic features, are important goals in oral health care. In this regard the application of calcium and other mineral-containing agents continues to be an effective and widely used treatment for the prevention of cavities and remineralization of teeth and bone. Although effective in most cases, it is not without its drawbacks. Conventional mineral treatments are only marginally effective in providing useful minerals to teeth and enamel, and a large proportion of the so-applied minerals are unabsorbed and passed on into, and ultimately through, the body.
- Clearly then, there is a need for mineral delivery compounds that can help prevent cavities and that can also aid in the reconstruction of damaged teeth and bone. There is also a continuing need for materials that exhibit high absorption characteristics. Various embodiments discussed herein address these needs.
- With respect to the production of functionalized materials, there are few practical chemical processes that allow for industry-sized scaling. These techniques, as well as other well-known chemistries, include hydrothermal/solvothermal synthesis, micellar templates, and controlled growth in hot volatile solvents. Although these and other chemistries exist for creating functionalized materials, they are generally characterized by one or more of the following drawbacks: 1) wide temperature variations, 2) need for volatile solvents to effectuate dissolution of one or more phases, 3) reduced pressure systems to alleviate oxygen or water contact with reagents, 4) expensive templating molecules or multi-step syntheses, and 5) excessive overhead, including scientific expertise, laboratory space, and equipment.
- Thus, there remains a need for a process for more efficiently producing functionalized materials, such as micro-, meso, and nanoscale organic/inorganic hybrid composites, without the use of solvents and on a large, industrial scale. These functionalized materials may compliment new and/or existing dental product formulations (with or without fluoride), such as gels, varnishes, pastes, rinses, adhesives, filling materials and the like, for the repair of weakened dentition. The present novel technology addresses these needs.
- The present novel technology relates generally to the production of functionalized hybrid moieties without the need for sophisticated chemistries, and, more particularly to a solid-state method for producing the same.
- One object of the present novel technology is to provide an improved method for producing functionalized hybrid moieties for the purposes of delivering superior performance in oral care product formulations in the absence or presence of fluoride. Further objects, features, and advantages will become apparent from a consideration of the following description and accompanying drawings.
-
FIG. 1 is a graph showing the change in Vickers microhardness results from remin/demin cycling study including a negative control group (water) and positive control ACP and test group ACP95PEG15, comprised of 95 and 5 weight percent of TCP and 1500 Da PEG. -
FIG. 2 is a graph showing the change in Vickers microhardness of human enamel after application of a 5% NaF commercially available varnish with and without the additive TCP90FA10, a construct of 90 wt. % TCP and 10 wt. % fumaric acid. -
FIG. 3 is a graph showing the change in Vickers microhardness results after 7 days of a pH cycling lesion reversal dental model in experimental groups including commercially available 5000 ppm fluoride products A and B (positive controls) and Product A combined with different functionalized calcium phosphates: TCP98SLS2 [construct of 98% TCP plus 2% sodium lauryl sulfate, SLS], TCP98PCL2 [construct of 98% TCP plus 2% 2000 Da polycaprolactone, PCL], or TCP95CPC5 [construct of 95% TCP plus 5% cetylpyridinium chloride, CPC]. -
FIG. 4 is a graph showing enamel fluoride uptake results after 7 days of a pH cycling lesion reversal dental model in test groups including commercially available 5000 ppm fluoride products A and B, as well as Product A combined with different functionalized calcium phosphates: TCP98SLS2 [construct of 98% TCP plus 2% sodium lauryl sulfate, SLS], TCP98PCL2 [construct of 98% TCP plus 2% 2000 Da polycaprolactone, PCL], or TCP95CPC5 [construct of 95% TCP plus 5% cetylpyridinium chloride, CPC]. - For the purposes of promoting an understanding of the principles of the novel technology, reference will now be made to the embodiments illustrated in the drawings and specific language will be used to describe the same. It will nevertheless be understood that no limitation of the scope of the novel technology is thereby intended, such alterations and further modifications in the illustrated device, and such further applications of the principles of the novel technology as illustrated therein being contemplated as would normally occur to one skilled in the art to which the novel technology relates.
- The present novel technology relates to a method of combination of organic and inorganic chemical systems in such a way as to eliminate the usual synthetic procedures requiring 1) temperature variations (both hot and cold), 2) the need for volatile solvents to effectuate dissolution of one or more phases to be blended, 3) vacuum or inert environment conditions to reduce oxygen or water vapor interaction, 4) templating molecules, 5) the usual overhead in terms of laboratory space, equipment, professional expertise in terms of synthesis. Additionally, the method may be easily scaled from the synthesis of gram amounts to the synthesis of tons, overcoming a production limitation that economically and operationally impedes the use of known functionalizing chemistries for large scale production of functionalized materials.
- The present novel technology includes a method for producing a thermodynamically and kinetically stable material that slowly releases ions and moieties due to the complex chemistry created during the alloying process. The technique was developed to address a need for improved dental applications, and, accordingly, the following examples and embodiments tend to reflect chemistries having dental applications. However, the present novel method for producing functionalized chemistries is broadly applicable beyond the dental applications discussed herein.
- Typically, the hybrid materials may coexist with fluoride and do not compromise fluoride bioavailability. The formation and/or retention of chemical structures facilitate and modulate interactions among the hybrid materials and other components when added to condensed phases. At the same time, the functionalized surface aids in promoting direct contact between a target material (such as a pellicle, enamel, intestinal walls or the like), and therefore allows for more efficient delivery of a desired active component.
- The present novel technology may be used to generate functionalized hybrid materials on a nano-, meso-, and/or macroscale. The characteristics and properties of these materials typically include one or more of the following:
-
- the hybrid material improves remineralization efficacy by delivering small, surfactant-coated minerals to a substrate, such as dentition.
- the hybrid material is compatible with existing fluoride formulations so that increased benefit of bioavailable minerals, including calcium and fluoride, may be enjoyed.
- the synergistic effect of adding a functionalized nanomaterial to fluoride in a single treatment serves to improve oral health relative to existing treatments.
- Mechanochemical (MC) ball milling not only reduces particle size but also impacts particles with sufficient force that such disparate materials as oxides, ceramics, organic powders and the like maybe chemically combined together to form new alloys or composites. This mechanochemical synthesis process occurs entirely in the solid state. This capability separates MC ball mills from traditional mills. This destructive process deforms components through powerful collisions between ball-particle, particle-wall, and particle-particle. These collisions are sufficiently energetic to give rise to the formation of significant grain boundaries at the nanoscale where components have fractured and fused. In order to generate the energy required for such concurrent fracturing and fusion, the vessel containing the balls and material is typically rotated at high speed opposite to the direction of rotation of the platform on which the vessel is placed (i.e., mimicking ‘tilt-a-whirl’ motions). More particularly, the vessel is rotated in a first direction about an axis of rotation not passing through the vessel (i.e., the axis of rotation of the platform) while simultaneously rotated or spun in a second direction (i.e., about a second axis of rotation that is nonparallel to the first axis of rotation and typically, though not necessarily, passes through the vessel) to impart sufficient kinetic energy to the admixture within the vessel to both break down the precursor component parts of the admixture and fuse them together to generate a new hybrid compound.
- The resultant hybrid nanomaterials formed from these concurrent physical and chemical processes enable material synthesis to extend beyond both what is typical of usual wet laboratory synthetic procedures and of ball milling in a wet medium. For example, one such opportunity relates to the extraction of elements from fluorescent powder for energy conservation. Additionally, MC ball milling has been employed to improve nitrogen absorption characteristics of better materials as well as to synthesize nanoscale graphite platelets as an alternative to carbon nanotubes.
- Milling additives have been used in MC ball milling to improve properties of the milled material, but these additions have been primarily directed at expediting particle size reduction. The present novel technology uses MC ball milling for more than the simple reduction of the physical dimensions of the particles, but instead as a starting point for specific chemical modification to generate novel materials with improved properties and characteristics, such as when added to various formulations.
- One benefit of using the present high-energy milling method as an environment for fostering solid-state nanoscale chemical reactions is that MC milling is readily scaleable to met industrial demands. Typically, one robust industry-scale planetary ball mill has a commercial capacity ranging between 100 and 900 liters, and MC milling technology is currently used in developing improved nanosized pigments for coatings, lotions, and paints.
- The current novel technology introduces efficiencies of cost, time, and scale of producing functionalized hybrid moieties without the need for complex and sophisticated wet chemistries. The resulting scalability may then be realized for various applications, for example where localized, slow-releasing chemical, mineral or drug delivery is desired. Functionalizing systems to specifically adsorb to target areas offers alternatives for more effective therapeutic or chemical treatments.
- The novel chemical synthesis method exploits the mechanochemical ball milling process to produce a relatively great amount of relatively inexpensive functionalized complexes. Typically, the functionalized complexes are blends of independent organic and inorganic reagents coupled together to yield a hybrid material with enhanced properties. A typical inorganic material includes a calcium phosphate mineral such as calcium phosphate tribasic, calcium phosphate dibasic, dicalcium phosphate, and the like. Alternatively, other inorganic materials may include sodium, magnesium, iron, silicon, aluminum, manganese, titanium and the like in various mineralogical forms (carbonates, nitrides and the like).
- Typical organic materials include anionic surfactants (such as sodium lauryl sulfate, sodium lauryl ether sulfate, ammonium lauryl sulfate, N,N-Dimethyl-N-[3-(sulfoxy)propyl]-1-nonanaminium hydroxide inner salt, sodium dodecylbenzenesulfonate, poly(ethylene glycol) 4-nonylphenyl 3-sulfopropyl ether potassium salt, doctyl sulfosuccinate sodium salt, and the like), cationic surfactants (such as pyridinium chloride, hexadecyltrimethylammonium bromide, N,N-dimethyl-N-[3-(sulfoxy)propyl]-1-decanaminium hydroxide inner salt, and the like), neutral surfactants—polyethers or polyesters (such as polyethylene glycol, polypropylene glycol (PPG), poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol), poly(ethylene oxide)-block-polycaprolactone, polycaprolactone diol, polycaprolactone triol, and the like), carboxylic acids (such as fumaric acid, acrylic acid, malic acid, citric acid, maleic acid, stearic acid, and the like), polymethyl methacrylate, or the like. In other words, the organic materials may include those with properties akin to the anionic surfactants listed above (i.e., materials having anionic terminal groups (such as sulfates, sulfonates, or carboxylates), having cationic species ionically bound (such as sodium or potassium ions), having aliphatic chain lengths up to 12 carbon atoms or even more, and/or having the character of sodium lauryl sulfate in its structures (such as sodium laureth sulfate, which manifests n-number of ethoxy groups (OCH2CH2)n)), having properties akin to the cationic surfactants listed above (i.e., having quaternary ammonium cation character manifested in a conjugated carbon ring, having anionic species ionically bound (such as chlorine and bromide ions), and/or having aliphatic chain lengths up to 17 carbon atoms or more), having properties akin to the polyether surfactants listed above (i.e., having no charges manifested in its structure (i.e. they are neutral), terminated with hydroxyl groups (i.e. OH), having ether monomer lengths from n=about 13 to n=about 150, and/or having the ether linkage (C—O—C)), having properties akin to the polyester surfactants listed above (i.e., having no charges manifested in its structure (i.e. they are neutral), having ester monomer lengths from n=about 10 to n=about 150, and/or having the non-ring ester linkage (O—(CH2)5—C═O)), organic acids, and the like. For example, hybrid polymer-calcium phosphate systems may be produced in various formulations for improving remineralization efficacy of a fluoride rinse or paste or reducing tooth sensitivity in a paste or varnish.
- The preparation of organic-inorganic materials via a mechanochemical process is described as follows. Depending upon the desired composition, the mixture may range from between about 0.5 and 99.5 weight percent inorganic precursor material, with the balance being organic precursor material. In this example, the inorganic starting material is tricalcium phosphate, while the organic starting material is polyethylene glycol; however, any convenient inorganic and organic precursors may be selected. Tricalcium phosphate (TCP, Ca3(PO4)2) may be purchased from a chemical vendor directly or may be formed by adding equal masses of calcium carbonate (CaCO3) and dibasic calcium phosphate (CaHPO4.2H2O) to a refractory crucible and heating the mixture in an oven at about 1050° C. for about 24 hours to produce a resultant flaky, stiff powder crystalline TCP. TCP plus polyethylene glycol (PEG) having any one of various molecular weights (such as 600, 1500, and 6000 Da) may be added to a stainless steel vessel containing a plurality of milling media balls, such as about twenty-five 10 millimeter diameter stainless steel balls. PEG is typically substituted for TCP between 0 and 20 weight percent (wt. %). Additionally, a small amount of organic solvent, such as pentane, may be added to not only swell the PEG to encourage more uniform blending, but also to help prevent powder from caking onto the balls and walls of the vessel. Once loaded with the chemical precursors and milling media, the vessel is typically locked onto the sun wheel of a planetary ball mill. The vessel is then rotated unidirectionally and opposite the rotational direction of the sun wheel at a sufficiently high speed for a duration of time sufficient to yield functionalized chemical moieties, such as, for example, at about 550 rpm or more for about two hours. At the end of the milling process the resulting powders are then filtered from the balls and stored, such as in plastic containers.
- In laboratory testing, particle-size measurements of so-produced powders typically revealed particle size distributions between 100 and 1000 nm, depending on the powder formulation. Even smaller sizes along grain boundaries may exist due to extensive breakdown and recombination or ‘welding’ of the particulates during the MC milling process. Also, the texture and appearance of the powders may vary considerably with the composition of the selected organic and inorganic precursors, the milling media composition, size and number, the milling energy, the milling time, and like factors. For instance, milling the TCP powder in the absence of PEG typically produces fine, hard particles, while milling in the presence of PEG, however, powders that vary from fluffy and soft to inflexible and coarse with increasing PEG molecular weight and content. These rudimentary powder observations suggest a composite-like material might have been formed, as neither the singular forms of TCP nor the PEG exhibit such characteristics.
- The integrity of the P2O5 network and calcium environments inherent to a calcium phosphate mineral can be modified with the addition of an organic additive (e.g., a polymer having varied molecular weight and chemical character, a surfactant such as SLS, and a carboxylic acid such as fumaric acid) and prepared under a variety of milling conditions. During the milling event, solid-state interactions between the calcium phosphate material and the organic component create functionalized calcium phosphate hybrid materials with widely varying chemical and physical properties depending on material components and milling conditions. Spectroscopic investigations show that the microstructure of the resultant hybrid material after a milling event is unique to the singular structures of both the calcium phosphate mineral as well as the organic component; additionally, the structures vary significantly from one hybrid to another depending on the additive and milling conditions. Also, the texture, solubility, and particle-size of the resultant functionalized calcium phosphate materials also vary considerably. One benefit of these structural modifications is the resulting compatibility of the functionalized calcium phosphate with bioavailable fluoride. Another benefit is that the functionalized calcium phosphate can enhance the action of fluoride when interfaced with a substrate, such as the enamel and dentin of the tooth. The impact of these structural modifications on the resultant functionalized composition's interaction with fluoride and the dentition (enamel, dentin) has been examined using FDA-based and scientifically-accepted dental testing models and methods, and is discussed below.
- Functionalized Calcium Phosphate Stability with Fluoride
- Typically to be considered a candidate in improving the effectiveness of a fluoride-based formulation, it is generally required that any added materials to the formulation do not inhibit the bioavailability (typically greater than ±50% of the theoretical ppm level, more typically greater than ±10% of the theoretical ppm level) or action of fluoride. A pilot study assessing the compatibility potential of a TCP (tricalcium phosphate)—PEG (polyethylene glycol) nanocomplex material prepared according to the novel methodology herein when added to NaF(aq) over a period of 26 days did not reduce fluoride bioavailability greater than 10%, while a soluble form of calcium acting as a control reduced bioavailable fluoride nearly 60%. The TCP and PEG precursors were introduced into a MC mill and were milled with sufficient energies to break down the organic and inorganic precursors into organic and inorganic components and fuse or couple the components to form functionalized complexes or moieties. Other compatibility studies with different functionalized calcium phosphates (for example, TCP98SLS2, which is a construct of 98% TCP plus 2% sodium lauryl sulfate, SLS) in the presence of 500, 1100, and 5000 ppm fluoride (from NaF) have shown less than 10% bioavailable fluoride reduction over an accelerated aging period (temperature set to 40° C.) of at least 30 days (which is the equivalent to approximately 6 months at 20° C.).
- The following study was circulated to assess enamel remineralization efficacy of the functionalized hybrid calcium phosphate system relative to an unfunctionalized calcium phosphate system. The difference between post and baseline Vickers microhardness indentations was used as the analytical method assessing remineralization.
- The nomenclature to describe the test groups (2 and 3) in the cycling study showing the remineralization potential of the polymer-calcium phosphate hybrid is described as follows. TCP is tricalcium phosphate and TCPXPEGy represents an alloyed material comprised of 1500 Da PEG, where x represents the weight percent of TCP in the composite (i.e. 95%) and y represents the fraction of PEG (i.e. 5%).
- The test materials (
groups 2 and 3) were prepared using a solid-state mechanochemical milling procedure that pulverized 20 grams of thermally prepared TCP for 2 hours at 550 rpms, unidirectionally, using twenty-four 10 mm diameter stainless steel balls and 20 ml of pentane. After milling, the powder was extracted from the mill jar and placed in 120 ml plastic containers.Groups - Enamel specimens (5 mm×5 mm) were removed from extracted bovine teeth and mounted in rods. The specimens were ground and polished to a high luster with Gamma Alumina using standard methods. Ten specimens per group were prepared for this study.
- Artificial lesions were formed in bovine enamel specimens by a 96-hour immersion into 12.0 ml of a solution of 0.1 M lactic acid and 0.2% Carbopol C907 which has been 50% saturated with hydroxyapatite and adjusted to pH 5.0 at 37° C. The lesion surface hardness range was 20-50 and average lesion depth was approximately 70μ.
- The mass of the treatment powders was 30 mg (for a weight fraction of 6% with respect to the 5 g of water). There were a total of 20 treatments per group. There were a total of 3 groups in this study and they are identified as follows:
- Group 1: Water (negative control)
- The cyclic treatment regimen consisted of a 4.0 hour/day acid challenge in the lesion forming solution and four, one-minute dentifrice treatment periods. After the treatments, the specimens were rinsed with running distilled water and then placed back into the artificial saliva. The remaining time (˜21 hours) the specimens were in an artificial saliva/remineralization system. The regimen was repeated for 5 days.
- Remineralization was determined by comparing the Vickers surface microhardness after treatment (post) to that before treatment (baseline).
- The mean and SEM of each parameter for each group were calculated. The Student Q-test was used to assess the accuracy of the individual specimen measurements and ANOVA was used to verify significant differences among the groups (p<0.05). Multiple t-tests were performed to identify where the differences were. Group means and standard deviations were plotted to help illustrate significances.
- The results are charted below in
FIG. 1 , where the composition comprising 5 wt. % of 1500 Da PEG and 95 wt. % TCP is numerically and significantly different than both water (negative control) and unmodified TCP. - The novel technology hybrid material prepared according to the novel methods disclosed herein may produce increased levels of remineralization relative to an unfunctionalized calcium phosphate when used in a standard pH cycling lesion reversal model.
- Calcium phosphate additives were prepared by blending fumaric acid with tricalcium phosphate. The fumaric acid has a high melting point (˜300 degrees Celsius) and manifests an unsaturated environment that can be activated to react with, for example, the tricalcium phosphate when subjected to high impact forces and energies inherent in the novel mechanochemical process discussed herein. The following data report the application findings when this high temperature, unsaturated organic molecule is blended forcibly with an inorganic salt (tricalcium phosphate) to yield a dental treatment complex and implemented into a tooth surface introduction medium, such as a fluoride-containing commercial varnish having 5% NaF.
- Ten enamel specimens were used in each group, with specimens initially demineralized for 18 hours at 37° C. in a carbopol-lactic acid demineralization solution (baseline microhardness values of enamel ranged between about 75 and about 115 Vickers Hardness Number, VHN). This challenge was performed to mimic softening of enamel due to early caries formation. Varnishes were left on enamel specimens for 24 hours and immersed in artificial saliva. After the 24-hour period the varnishes were removed and measured for Vickers surface microhardness (200 gf for 15 seconds). The change in VHN (i.e. post VHN—baseline VHN) are presented in
FIG. 2 . Statistical differences were found using Kruskal-Wallis One Way Analysis of Variance. The SNK method was used determine where the differences occurred (p<0.05). Only the 5% NaF Varnish+1 wt. % TCP90FA10 system was statistically different from the Placebo group; the other two groups were statistically equivalent (seeFIG. 2 ). - Additives comprised of sodium lauryl sulfate, cetylpyridinium chloride, polycaprolactone and tricalcium phosphate and validated in a pH cycling lesion reversal remineralization model
- The use of prescription-based NaF toothpaste is suggested for certain population groups most at risk for developing caries. These pastes typically have 5000 ppm F and are used at least once daily as a replacement for the conventional 1100 ppm F paste in order to provide increased protection. To further increase protection, improved performance can be achieved with custom-made calcium phosphate additives that have been added to existing tooth care formulations, such as commercially available 5000 ppm F dentifrice formulations. In one screening study, the extent of remineralization and fluoride uptake into white-spot enamel lesions when treated with modified tooth care formulations was investigated.
- The protocol for this screening study was performed as follows. Bovine enamel specimens were demineralized for 40 hours in a Carbopol-lactic acid ‘white-spot’ solution. White-spot lesions of approximately 70 microns were formed. The specimen microhardness ranged between 25 and 45 Vickers hardness numbers. Three enamel specimens were used for each of the treatment groups. The treatment groups consisted of a negative control (DI water), positive commercially available 5000 ppm F controls (product A and B), and experimental test groups comprised of commercially available product A combined with various additives. During treatment periods, artificial saliva was added to the test formulation in a 1:2 ratio (e.g. 5 g paste, 10 g artificial saliva).
- The remineralization/demineralization pH cycling model used to evaluate the efficacy of the test groups is described as follows. Each 24-hour period consisted of four, two minute treatments from the groups described above, one, four-hour acid challenge emulating caries formation, and the remaining time the specimens were immersed in artificial saliva. The cycle was repeated for seven days, after which post microhardness and fluoride uptake measurements were performed on all enamel specimens.
- There were a total of 6 groups in this study and they are identified as follows:
Group 1: Water (negative control) - Group 4: 5000 ppm F Product A+0.2% TCP98PCL2[PCL=polycaprolactone]
Group 5: 5000 ppm F Product A+0.1% TCP95CPC5 [CPC=cetylpyridinium chloride]
Group 6: 5000 ppm F Product A+0.2% TCP98SLS2 [SLS=sodium lauryl sulfate] - The extent of remineralization is the difference between post and baseline Vickers microhardness indentations of the enamel specimens and is reported as ΔVHN. ΔVHN is plotted in
FIG. 3 for the six groups listed above. Although only three specimens were used in each group in this pilot validation study, overall the relatively small standard errors suggest the microhardness range is acceptable for this study. The addition of functionalized calcium phosphate additives significantly improved the efficacy of the base 5000 ppm F Product A formulation by almost 30 VHN. - To further probe the remineralization efficacy, fluoride uptake measurements were made by drilling the enamel specimens, collecting the powder, and dissolving it in perchloric acid. The concentration of fluoride in the dissolved enamel was measured with a calibrated fluoride electrode and the results are presented in
FIG. 4 . These data show that the additives significantly increase fluoride incorporation into enamel almost twice as much as the base 5000 ppm F Product A formulation. - That fluoride-stable additives can improve fluoride uptake and remineralization and indicate that these agents function synergistically with the 5000 ppm F Product A formulation when examined in a seven day pH cycling model. The overall effect is a net remineralization of enamel. The additives do not appear to compromise and can improve the performance of Product A.
- Sound
bovine dentin specimens 3 mm in diameter were extracted from teeth and mounted in rods. The specimens were ground and polished to a high luster with Gamma Alumina (0.050 microns) using standard methods. - The dentin specimens were initially demineralized for 10 minutes in dilute perchloric acid to dissolve calcium phosphate mineral within the tubes. After initial demineralization, baseline images were taken of each specimen using a reflective light microscope at 500× magnification. Ten specimens per group were prepared for each study. The groups were subjected to a 10-day pH cycling regimen consisting of two two-minute treatments and three three-minute acid challenge periods (COCA-COLA CLASSIC®, pH=2.65). (COCA-COLA CLASSIC is a Registered Trademark, Serial No. 74381727, of the COCA-COLA COMPANY, a Delaware Corporation, located at One Coca-Cola Plaza, Atlanta, Ga. 30313.) In between the treatments and acid challenges the specimens were immersed in artificial saliva. During the treatment period, the treatment pastes were diluted with DI water in a ratio of 1:3 (i.e. 5 ml of test solution: 15 ml DI water). The treatments consisted of: (a) a commercially available product for reducing dentinal hypersensitivity by occluding exposed dentinal tubules; (b) a similar product containing 1100 ppm fluoride to which 0.05% TCP98SLS had been added; (c) a similar product containing 5000 ppm fluoride; and (d) the latter product to which 0.1% TP98SLS2 had been added.
- After the 10-day cycling period, specimens were examined optically. A second cycling study for five days was then employed to further improve mineral retention and/or formation in and on the dentin tubules. This study lacked acid challenges and instead consisted of three five-minute treatment periods.
- After five days of cycling, images were taken again. The specimens were then subjected to one 30-minute treatment period (again a 1:3 dilution using DI water) and then immersed in artificial saliva and placed in an incubator at 37° C. for six days. During this time fresh artificial saliva was replaced daily. The specimens were then removed from the saliva after six days, lightly rinsed with DI water and dried in an oven at 37° C. for one hour. Optical images were then taken of the specimens.
- The results of this study clearly indicated that the presence of the additives described in this invention enhanced the occlusion of the exposed dentinal tubules and therefore would be expected to decrease dentinal hypersensitivity more effectively than currently available products.
- While the novel technology has been illustrated and described in detail in the foregoing examples, the same is to be considered as illustrative and not restrictive in character, it being understood that only the preferred embodiments have been shown and described and that all changes and modifications that come within the spirit of the novel technology are desired to be protected.
Claims (31)
1. A method of repairing weakened teeth, comprising:
a) combining a first predetermined amount of an inorganic calcium source with a second predetermined amount of an organic material to define a mixture;
b) placing the mixture in a milling vessel operationally connected to a planetary mill;
c) introducing milling media into the milling vessel;
d) milling the mixture to impart sufficient kinetic energy to break down the organic and inorganic materials into substantially smaller intermediate particles and fuse the intermediate particles together to yield functionalized molecules having both organic and inorganic chemical characteristics;
e) combining a functionalized calcium phosphate/organic compound with a fluoridated formulation to define a hybrid system;
f) applying the hybrid system to the weakened teeth.
2. The method of claim 1 wherein the functionalized calcium phosphate/organic compound generally includes between 0.5 and 99.5 weight percent of a calcium phosphate mineral including tricalcium phosphate and generally includes between 0.5 and 99.5 weight percent of an organic component.
3. The method of claim 1 wherein the organic material is a neutral surfactant or polyether and is selected from the group including polyethylene glycol (PEG), polypropylene glycol (PPG), poly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol); and wherein the material has no charges manifested in its structure; and wherein the material is terminated with hydroxyl groups; and wherein those materials have ether linkage and ether monomer lengths between n=13 and n=150.
4. The method of claim 1 wherein the organic component is a carboxylic acid and is selected from the group including fumaric acid, acrylic acid, malic acid, citric acid, maleic acid, stearic acid and combinations thereof; and wherein those materials having carboxylic acid character; and wherein the carboxylic acid functional groups are connected via saturated or unsaturated carbon bonds.
5. The method of claim 1 wherein the organic component is a negative surfactant and is selected from the group including sodium lauryl sulfate, sodium lauryl ether sulfate, ammonium lauryl sulfate, N,N-Dimethyl-N-[3-(sulfoxy)propyl]-1-nonanaminium hydroxide inner salt, sodium dodecylbenzenesulfonate, poly(ethylene glycol) 4-nonylphenyl 3-sulfopropyl ether potassium salt, doctyl sulfosuccinate sodium salt and combinations thereof; and wherein the cationic species of the material are ionically bound; and wherein the material has anionic functionalities; and wherein the aliphatic character of the material extends up to at least 12 carbon atoms; and wherein the material manifests ethoxy functionalities (OCH2CH2)n).
6. The method of claim 1 wherein the organic component is a positive surfactant and is selected from the group including cetylpyridinium chloride, pyridinium chloride, hexadecyltrimethylammonium bromide, N,N-Dimethyl-N-[3-(sulfoxy)propyl]-1-decanaminium hydroxide inner salt and combinations thereof; and wherein the materials have quaternary ammonium cation character manifested in a conjugated carbon ring; and wherein the materials have anionic species are ionically bound; and wherein the aliphatic chain length extends up to at least 17 carbon atoms.
7. The method of claim 1 wherein the organic component is a neutral surfactant or polyester and is selected from the group including polycaprolactone, poly(ethylene oxide)-block-polycaprolactone, polycaprolactone diol, polycaprolactone triol and combinations thereof; and wherein the materials are neutral; and wherein the materials manifest ester monomer lengths between at least 10 and 150; and wherein the material manifests non-ring ester linkages (O—(CH2)5—C═O)).
8. The method of claim 1 wherein the hybrid system is added to a member of the group including toothpaste, dental gel, varnish, oral rinse, to define a hybrid oral dental application.
9. A method of reducing tooth sensitivity in a patient, comprising:
a) mechanochemically fusing an organic material with an inorganic material to yield a functionalized complex;
b) applying the functionalized complex to the tooth surface of a patient; and
c) occluding tubules opening onto the tooth surface.
10. The method of claim 9 , wherein the organic component is selected from the group including anionic surfactants, cationic surfactants, neutral surfactants, carboxylic acids, polymers, copolymers, block copolymers, and combinations thereof and wherein the inorganic component contains calcium.
11. The method of claim 10 wherein the inorganic component is tricalcium phosphate.
12. A dental composition, comprising:
A functionalized complex including an organic component coupled to an inorganic component; and
a fluoride-containing component;
wherein the coupling of the organic and inorganic components is achieved through mechanochemically reacting organic precursors and inorganic precursors in a high-energy planetary ball mill;
wherein the mechanochemical milling occurs substantially in the solid state; and
wherein the mechanochemical milling is sufficiently energetic to break down the organic precursors and inorganic precursor into organic and inorganic components and to fuse organic and inorganic components into functionalized complexes.
13. The dental composition of claim 12 wherein the organic precursor is selected from the group including anionic surfactants, cationic surfactants, neutral surfactants, carboxylic acids, polymers, copolymers, block copolymers, and combinations thereof; wherein the inorganic precursor contains calcium; and wherein the fluoride-containing component is aqueous sodium fluoride.
14. The dental composition of claim 13 wherein the inorganic precursor is tri-calcium phosphate.
15. The dental composition of claim 12 wherein the functionalized complex is incorporated into a medium selected from the group including gels, varnishes, pastes, rinses, adhesives, filling materials, reconstructive materials and combinations thereof.
16. A method of reminerzalizing a tooth, comprising:
a) mechanochemically combining an organic precursor with a calcium-containing inorganic precursor to yield a functionalized nanocomplex;
b) introducing the functionalized nanocomplex to a mineral-depleted tooth; and
c) increasing the mineral content of the tooth;
wherein the functionalized nanocomplex is a surfactant-coated mineral.
17. The method of claim 16 , wherein the organic precursor is selected from the group including anionic surfactants, cationic surfactants, neutral surfactants, and combinations thereof; wherein the inorganic precursor is tri-calcium phosphate.
18. The method of claim 17 wherein the organic precursor is polyethylene glycol.
19. A method of enhancing the bioavailability of fluoride in a dental composition, comprising:
a) mechanochemically synthesizing a nanocomplex material from an inorganic calcium-containing precursor and an organic precursor;
b) combining the nanocomplex material with an aqueous fluoride source to yield a dental treatment composition;
c) introducing the dental treatment composition to a patient's tooth;
wherein the bioactivity of the aqueous fluoride source is diminished by no more than 50 percent.
20. The method of claim 19 wherein the aqueous fluoride source is aqueous sodium fluoride and wherein the dental treatment composition contains between 0.5 and 20 weight percent hybrid calcium phosphate material.
21. The method of claim 20 wherein the organic precursor is polyethylene glycol.
22. The method of claim 21 wherein the polyethylene glycol has a molecular weight of between 600 and 1500 Da.
23. The method of claim 19 wherein the dental treatment composition includes between 0.1 and 10 weight percent sodium lauryl sulfate.
24. A product for treating dental disorders, comprising:
a tooth surface introduction medium; and
a dental treatment complex mixed with the tooth surface introduction medium;
wherein the dental treatment complex is formed by mechanochemically combining an organic precursor with a calcium-containing inorganic precursor; and
wherein the tooth surface introduction medium is selected from the group including gels, pastes, varnishes, fillers, reconstructives and rinses.
25. The dental product of claim 24 wherein the organic precursor is selected from the group including anionic surfactants, cationic surfactants, neutral surfactants, carboxylic acids, polymers, copolymers, block copolymers, and combinations thereof and where the inorganic precursor is tri-calcium phosphate.
26. The dental product of claim 25 wherein the organic precursor is a polymer.
27. The dental product of claim 26 wherein the organic precursor is polyethylene glycol.
28. The dental product of claim 24 wherein aqueous sodium fluoride is mixed with the tooth surface introduction medium.
29. A method of treating a tooth to prevent dental disorders, comprising:
a) mechanochemically combining an inorganic calcium-containing precursor and an organic precursor to yield a dental treatment complex;
b) combining the dental treatment complex with an aqueous fluoride source to yield a dental treatment composition;
c) introducing the dental treatment complex to a tooth;
d) reinforcing the tooth to resist the formation of caries and other dental disorders.
30. The method of claim 29 wherein the inorganic precursor is a calcium phosphate and wherein the organic precursor is a polymer.
31. The method of claim 30 wherein the polymer is polyethylene glycol and wherein the polymer has a molecular weight of between 600 and 1500 Da.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/105,268 US20120114718A1 (en) | 2007-02-06 | 2011-05-11 | Solid-state method for producing functionalized calcium phosphate hybrid organic/inorganic chemical systems for dental remineralization applications |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88835407P | 2007-02-06 | 2007-02-06 | |
US89184907P | 2007-02-27 | 2007-02-27 | |
US94109507P | 2007-05-31 | 2007-05-31 | |
US12/018,627 US8556553B2 (en) | 2007-02-06 | 2008-01-23 | Hybrid organic/inorganic chemical hybrid systems, including functionalized calcium phosphate hybrid systems, and a solid-state method for producing the same |
US13/105,268 US20120114718A1 (en) | 2007-02-06 | 2011-05-11 | Solid-state method for producing functionalized calcium phosphate hybrid organic/inorganic chemical systems for dental remineralization applications |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/018,627 Division US8556553B2 (en) | 2007-01-31 | 2008-01-23 | Hybrid organic/inorganic chemical hybrid systems, including functionalized calcium phosphate hybrid systems, and a solid-state method for producing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
US20120114718A1 true US20120114718A1 (en) | 2012-05-10 |
Family
ID=39676342
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/018,627 Active 2030-09-02 US8556553B2 (en) | 2007-01-31 | 2008-01-23 | Hybrid organic/inorganic chemical hybrid systems, including functionalized calcium phosphate hybrid systems, and a solid-state method for producing the same |
US13/105,268 Abandoned US20120114718A1 (en) | 2007-02-06 | 2011-05-11 | Solid-state method for producing functionalized calcium phosphate hybrid organic/inorganic chemical systems for dental remineralization applications |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/018,627 Active 2030-09-02 US8556553B2 (en) | 2007-01-31 | 2008-01-23 | Hybrid organic/inorganic chemical hybrid systems, including functionalized calcium phosphate hybrid systems, and a solid-state method for producing the same |
Country Status (7)
Country | Link |
---|---|
US (2) | US8556553B2 (en) |
EP (1) | EP2120842B1 (en) |
AU (1) | AU2008248087B2 (en) |
BR (1) | BRPI0807003A2 (en) |
CA (1) | CA2677611C (en) |
MX (1) | MX2009008331A (en) |
WO (1) | WO2008137190A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018204795A1 (en) * | 2017-05-04 | 2018-11-08 | Phoenix Dental, Inc. | Dental composition and method |
CN108853023A (en) * | 2018-07-05 | 2018-11-23 | 广州立白企业集团有限公司 | Oral cavity bacteriostatic composition and the preparation method and application thereof |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1811944B1 (en) | 2004-11-16 | 2010-09-08 | 3M Innovative Properties Company | Compositions including a caseinate treated dental filler |
WO2006055327A1 (en) * | 2004-11-16 | 2006-05-26 | 3M Innovative Properties Company | Dental fillers and compositions including phosphate salts |
US10130561B2 (en) * | 2006-01-31 | 2018-11-20 | Robert L. Karlinsey | Functionalized calcium phosphate hybrid systems for confectionery and foodstuff applications |
US9205036B2 (en) | 2007-01-31 | 2015-12-08 | Robert Karlinsey | Dental composition |
US9023373B2 (en) * | 2007-01-31 | 2015-05-05 | Indiana Nanotech | Functionalized calcium phosphate hybrid systems for the remineralization of teeth and a method for producing the same |
EP2120842B1 (en) | 2007-02-06 | 2019-08-21 | Indiana Nanotech Division of Therametric Technologies, INC. | Hybrid organic/inorganic chemical hybrid systems, including functionalized calcium phosphate hybrid systems, and a solid-state method of producing the same |
US8568696B2 (en) * | 2008-08-06 | 2013-10-29 | Indiana Nanotech Llc | Grinding method for the manipulation or preservation of calcium phosphate hybrid properties |
US8603441B2 (en) * | 2008-09-12 | 2013-12-10 | Indiana Nanotech Llc | Functionalized calcium phosphate hybrid systems for confectionery and foodstuff applications |
WO2010068359A1 (en) | 2008-12-11 | 2010-06-17 | 3M Innovative Properties Company | Surface-treated calcium phosphate particles suitable for oral care and dental compositions |
US8632754B2 (en) | 2009-08-03 | 2014-01-21 | Mcneil-Ppc, Inc. | Tooth sensitivity treatment compositions |
US9060947B2 (en) | 2009-08-03 | 2015-06-23 | Mcneil-Ppc, Inc. | Tooth sensitivity treatment compositions |
US8603442B2 (en) | 2009-08-03 | 2013-12-10 | Mcneil-Ppc, Inc. | Tooth sensitivity treatment compositions |
EP2794028B1 (en) | 2011-12-20 | 2017-02-15 | Colgate-Palmolive Company | Oral care compositions |
US9107838B2 (en) | 2012-04-25 | 2015-08-18 | Therametrics Technologies, Inc. | Fluoride varnish |
WO2014124950A1 (en) | 2013-02-14 | 2014-08-21 | Glaxo Group Limited | Novel composition |
ES2971113T3 (en) | 2016-05-26 | 2024-06-03 | Solventum Intellectual Properties Company | Therapeutic toothpastes and their application |
EP4034077A1 (en) | 2019-09-26 | 2022-08-03 | 3M Innovative Properties Company | Oral care composition with ammonium alkyl sulfonate or carbonate components for treating caries |
WO2024123555A2 (en) * | 2022-12-05 | 2024-06-13 | Isp Investments Llc | Anhydrous oral care compositions of adducts of alkali metal pyrophosphates and peroxides |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998040406A1 (en) * | 1997-03-13 | 1998-09-17 | The University Of Melbourne | Calcium phosphopeptide complexes |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3190568A (en) | 1962-10-08 | 1965-06-22 | Freedman David | Cell disintegrating apparatus |
IL40067A (en) | 1972-08-08 | 1975-03-13 | Yeda Res & Dev | Ball mill |
US4018619A (en) | 1974-09-23 | 1977-04-19 | Iu Technology Corporation | Highly activated mixtures for constructing load bearing surfaces and method of making the same |
JPS60253454A (en) | 1984-03-24 | 1985-12-14 | 大日本塗料株式会社 | Bone lack part and gap part filler composition |
US4877603A (en) | 1987-12-18 | 1989-10-31 | The Procter & Gamble Company | Oral compositions |
DE69205736T2 (en) * | 1991-06-26 | 1996-06-13 | Nitta Gelatin Kk | Hardenable calcium phosphate-containing material for repairing living hard tissues. |
CA2143733A1 (en) * | 1994-03-02 | 1995-09-03 | Yoshikazu Umezu | Alpha-tricalcium phosphate ceramic and production method thereof |
US5639402A (en) | 1994-08-08 | 1997-06-17 | Barlow; Joel W. | Method for fabricating artificial bone implant green parts |
US5496399A (en) | 1994-08-23 | 1996-03-05 | Norian Corporation | Storage stable calcium phosphate cements |
US5833954A (en) | 1996-08-20 | 1998-11-10 | American Dental Association Health Foundation | Anti-carious chewing gums, candies, gels, toothpastes and dentifrices |
US20020037258A1 (en) * | 1999-08-05 | 2002-03-28 | Gregory P. Dodd | Dental composition for the mineral occlusion of dentinal tubules in sensitive teeth |
US6126097A (en) * | 1999-08-21 | 2000-10-03 | Nanotek Instruments, Inc. | High-energy planetary ball milling apparatus and method for the preparation of nanometer-sized powders |
US7387774B2 (en) * | 1999-11-12 | 2008-06-17 | The Procter & Gamble Co. | Method of enhancing fluoridation and mineralization of teeth |
US6334583B1 (en) * | 2000-02-25 | 2002-01-01 | Hui Li | Planetary high-energy ball mill and a milling method |
US6840961B2 (en) | 2001-12-21 | 2005-01-11 | Etex Corporation | Machinable preformed calcium phosphate bone substitute material implants |
EP1461006B1 (en) | 2002-01-03 | 2016-09-28 | The Procter & Gamble Company | Stable oral compositions comprising casein phosphopeptide complexes and fluoride |
KR20050012291A (en) * | 2002-06-19 | 2005-01-31 | 닥터.에이치.씨. 로버트 마티즈 스티프텅 | Hydraulic cement based on calcium phosphate for surgical use |
US7445769B2 (en) | 2002-10-31 | 2008-11-04 | Cadbury Adams Usa Llc | Compositions for removing stains from dental surfaces and methods of making and using the same |
US20040101494A1 (en) | 2002-11-26 | 2004-05-27 | Scott Douglas Craig | Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth |
PT1624904E (en) | 2003-05-22 | 2007-04-30 | Artoss Gmbh | Inorganic resorbable bone substitute material |
JP4577481B2 (en) | 2003-12-22 | 2010-11-10 | 日清紡ホールディングス株式会社 | Inorganic-organic composite functional composition |
WO2006086567A2 (en) * | 2005-02-10 | 2006-08-17 | Mettler-Toledo Autochem, Inc. | High throughput comminution/mixing method and apparatus |
US20060270752A1 (en) | 2005-05-26 | 2006-11-30 | Ada Foundation | Dental releasing materials |
WO2007089894A2 (en) | 2006-01-31 | 2007-08-09 | Indiana University Research & Technology Corporation | Materials and methods for manufacturing amorphous tricalcium phosphate and metal oxide alloys of amorphous tricalcium phosphate and methods of using the same |
AU2007212138B2 (en) | 2006-02-03 | 2010-12-16 | Wm. Wrigley Jr. Company | Calcium phosphate salts in oral compositions suitable as a tooth remineralizing agent |
EP2120842B1 (en) | 2007-02-06 | 2019-08-21 | Indiana Nanotech Division of Therametric Technologies, INC. | Hybrid organic/inorganic chemical hybrid systems, including functionalized calcium phosphate hybrid systems, and a solid-state method of producing the same |
-
2008
- 2008-01-23 EP EP08795787.4A patent/EP2120842B1/en active Active
- 2008-01-23 CA CA2677611A patent/CA2677611C/en active Active
- 2008-01-23 US US12/018,627 patent/US8556553B2/en active Active
- 2008-01-23 WO PCT/US2008/051795 patent/WO2008137190A2/en active Application Filing
- 2008-01-23 AU AU2008248087A patent/AU2008248087B2/en active Active
- 2008-01-23 BR BRPI0807003-2A2A patent/BRPI0807003A2/en active IP Right Grant
- 2008-01-23 MX MX2009008331A patent/MX2009008331A/en active IP Right Grant
-
2011
- 2011-05-11 US US13/105,268 patent/US20120114718A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998040406A1 (en) * | 1997-03-13 | 1998-09-17 | The University Of Melbourne | Calcium phosphopeptide complexes |
Non-Patent Citations (1)
Title |
---|
Busch, "Regeneration of Human Tooth Enamel." Angewandte Chemie International Edition 2004:43(11);1428-1431. * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018204795A1 (en) * | 2017-05-04 | 2018-11-08 | Phoenix Dental, Inc. | Dental composition and method |
CN108853023A (en) * | 2018-07-05 | 2018-11-23 | 广州立白企业集团有限公司 | Oral cavity bacteriostatic composition and the preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CA2677611A1 (en) | 2008-11-13 |
EP2120842A2 (en) | 2009-11-25 |
MX2009008331A (en) | 2010-03-22 |
EP2120842B1 (en) | 2019-08-21 |
US8556553B2 (en) | 2013-10-15 |
EP2120842A4 (en) | 2014-10-08 |
WO2008137190A3 (en) | 2008-12-31 |
CA2677611C (en) | 2017-08-29 |
BRPI0807003A2 (en) | 2014-04-15 |
US20080187500A1 (en) | 2008-08-07 |
AU2008248087A1 (en) | 2008-11-13 |
WO2008137190A2 (en) | 2008-11-13 |
AU2008248087B2 (en) | 2013-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2008248087B2 (en) | Hybrid organic/inorganic chemical hybrid systems, including functionalized calcium phosphate hybrid systems, and a solid-state method of producing the same | |
Karlinsey et al. | Preparation, characterization and in vitro efficacy of an acid-modified β-TCP material for dental hard-tissue remineralization | |
Weir et al. | Effect of calcium phosphate nanocomposite on in vitro remineralization of human dentin lesions | |
Fernando et al. | Bioactive glass for dentin remineralization: A systematic review | |
Karlinsey et al. | Solid-state preparation and dental application of an organically modified calcium phosphate | |
JP6348570B2 (en) | Hollow calcium phosphate particles | |
US20090175917A1 (en) | Tooth Bleaching Agent | |
JP6163641B2 (en) | Tooth surface film forming powder containing sintered apatite | |
US9023373B2 (en) | Functionalized calcium phosphate hybrid systems for the remineralization of teeth and a method for producing the same | |
US8568696B2 (en) | Grinding method for the manipulation or preservation of calcium phosphate hybrid properties | |
Dong et al. | Characterization and analysis of fluoride calcium silicate composite interface in remineralization of dental enamel | |
Zhang et al. | Remineralizing nanomaterials for minimally invasive dentistry | |
IT201800006753A1 (en) | STABILIZED AMORPHOUS CALCIUM PHOSPHATE DOPED WITH FLUORIDE IONS AND A PROCEDURE FOR PRODUCING IT | |
JP5653553B1 (en) | Ion sustained release gum composition | |
JP2022531557A (en) | Surface-treated magnesium or calcium ion-containing material as a white pigment in oral care compositions | |
Fathy et al. | Evaluation of incipient enamel-carious–like lesion treated with hydroxyapatite-chitosan nanocomposite hydrogel | |
BRPI0807003B1 (en) | HYBRID ORGANIC / INORGANIC CHEMICAL SYSTEMS, INCLUDING HYBRID FUNCTIONAL CALCIUM PHOSPHATE SYSTEMS, AND A SOLID STATE METHOD FOR PRODUCING THE SAME | |
Handa et al. | Scope of nanotechnology in dentistry-A review of literature | |
JP6555722B2 (en) | Tooth surface restoration material | |
Dobrota et al. | Dynamics of Dental Enamel Surface Remineralization under the Action of Toothpastes with Substituted Hydroxyapatite and Birch Extract | |
Dobrota et al. | Dynamics of Dental Enamel Surface Remineralization under the Action of Toothpastes with Substituted Hydroxyapatite and Birch Extract. Materials 2024, 17, 2038 | |
US8603441B2 (en) | Functionalized calcium phosphate hybrid systems for confectionery and foodstuff applications | |
US10130561B2 (en) | Functionalized calcium phosphate hybrid systems for confectionery and foodstuff applications | |
CN111714385A (en) | A kind of composite micro-nano particle formulation and its application | |
WO2023163647A1 (en) | Amorphous calcium magnesium fluoride phosphate particles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION |